INTRODUCTION
Total tau protein (hTau), its phosphorylated isoform at position 181 (p-Tau181P), and amyloid-␤ (A␤) peptides (A␤ 42 and A␤ 40 ) are the current accepted cerebrospinal fluid (CSF) biomarkers used as an aid in the diagnosis of Alzheimer's disease (AD) [1] [2] [3] [4] [5] . They help characterize atypical phenotypes, stratify patients in clinical trials, and predict AD conversion in prodromal forms [4, 6, 7] . Due notably to important between-center variability [2, 8, 9] , there is no consensus on their use and their cut-off values to define a CSF AD signature. Investigation of pre-analytical events affecting the levels of these biomarkers identified delay of processing, storage in different types of tubes, volume per tube, dilution with detergent-containing buffer, plasma contamination, and heat treatment as significant factors [10] [11] [12] [13] .
To minimize pre-analytical and analytical errors, standardized operating procedures have been proposed [8, 10, 11] . Importantly, they all recommend the use of polypropylene tubes instead of polystyrene or glass. However, only a descriptive study on influence of collection tubes onto the CSF A␤ 42 was conducted [14] . In a recent letter we reported major differences between collection tubes [15] . Here, we significantly extended this initial study. We completed the comparison in a real clinical workflow using four different collection tubes. We also extended our study of 11 polypropylene tubes, looking at their biomarker performance in relation with their plastic polymer composition.
Our results show that the use of polypropylene tubes does not guarantee satisfactory pre-analytical behavior. They also point to collection/sampling tubes being a major pre-analytical source of variability that could impact the significance of AD biological diagnosis.
MATERIALS AND METHODS

Study participants
Samples originated from biobanks generated in two French Clinical and Research Memory Centres (CMRRs) specialized in the care of cognitive disorders based in Lyon and Montpellier. Recruited patients gave their written informed consent to participate in the biobanks (registered # DC-2008-417). As the focus of this study was analytical, samples were selected to cover the different neurochemical situations corresponding to different diagnoses, and with variable concentrations of biomarkers (Fig. 1) . Samples were divided into 0.5 mL aliquots in polypropylene Eppendorf tubes (Protein LoBind, ref: 0030108.116.), stored at −80 • C (less than 6 month), and thawed immediately before quantification. In some cases ( Fig. 2A, B) , freshly thawed samples were distributed in ST-PP tubes for the indicated period of time at 2-8 • C, or were supplemented with human albumin for the indicated final concentrations and kept for 1 h in ST-PP tubes before measurement.
CSF sampling and analysis
In a second series of experiments (Fig. 3 , Tables 2), six non-hemorrhagic CSF samples were collected directly in the tube J (Table 1) , transported in less than 15 min to the laboratory and processed immediately by centrifugation (10 min, 1000 g). After homogenization, 300 l of the supernatant was distributed in every one of the 11 tubes (see Table 1 for description of tubes) and left for 15 min (T1) or 24 h (T2) at 2-8 • C. They were then stored at −80 • C and thawed before immediate quantification.
CSF A␤ 42 ,A␤ 40 , hTau, and p-Tau181P concentrations were measured using standardized commercially available INNOTEST ® /IBL sandwich ELISA tests according to the supplier's instructions (Innogenetics, Ghent, Belgium). To reduce variability, the analysis of each series was performed within same experiment using the same batch of kits. Intra-assays CVs were <5% for A␤s and p-Tau181P, and <8% for hTau.
Statistical analyses
Statistical analyses were performed and graphs prepared using XLSTAT and MedCalc (7.3) software. Graphical results were presented as medians and interquartile ranges. The impact of tube type was assessed using a non-parametric test on the percentage of concentration deviation for each tube to the average concentration value for each CSF sample. A KruskalWallis test was used for comparison of k samples with a significance level set at 5%. The tubes were compared two by two with a bilateral test using the Conover-Iman procedure.
Tube analysis
Physical analysis of the tubes was performed using two methods [16] . Differential scanning calorimetry, which is a measurement of a phase change of the material, those phase changes being characteristic for a material; melting points were measured and compared to polyolefin references. Fourier Transformed Infrared spectroscopy measures the absorption by a sample of polychromatic radiation in the infrared domain, this absorption being characteristic of the chemical groups present in the sample. Thus, the spectrum obtained is specific to the sample's material or to the material family. The spectra were acquired in reflexion mode giving a surface analysis with a probe depth of 1 to 5 m.
RESULTS
To investigate pre-analytical variations linked solely to sampling tubes, CSF samples from 12 patients enrolled in an ethically approved study were directly (from the lumbar puncture needle) collected in four different types of tubes: two polypropylene tubes, one polystyrene tube, and one polyethylene tube. hTau, p-Tau181P, A␤ 42 , and A␤ 40 concentrations were then measured in parallel (Fig. 1) .
When the results were expressed as a percentage of the median value obtain in the four tubes (Fig. 2) , biomarkers concentration showed major variations that were significantly different in many cases in particular for A␤ peptides (Fig. 1) . Median values for A␤ 42 peptides were for example of 80%, 137%, 81%, and 99% in BD-PP, ST-PP, BD-PE, and HE-PS tubes, respectively. In individual patient samples (Fig. 1) , this effect was present over the whole range of A␤ values. These data confirmed and extended previous observation by Pica-Mendez et al. [14] .
In summary, much higher A␤ 42 and A␤ 40 concentrations were observed in ST-PP tubes compared to the other tubes. Statistical differences between non polypropylene tubes were also observed for hTau (HE-PS) and p-Tau181P (BD-PE) (Fig. 1) . This clearly illustrated that each tube has its own pre-analytical property.
In contrast with common knowledge and recommendations, it was clear that using polypropylene tubes did not always result in optimal pre-analytical behavior. Importantly, the type of tube used for the same patient could dramatically change the interpretation of the biomarker results, leading therefore to possible AD misdiagnosis (see individual concentration values on Fig. 1 ). hTau and p-Tau181P were, however, less affected by the type of tubes, confirming the importance of evaluating A␤ peptides concentration in combination with these biomarkers.
To further explain the role of collection tubes on resulting biomarker values, we selected 11 different commercially available polypropylene collection tubes (Table 1) , some of them being used by different clinical teams in the AD field. We performed an evaluation Table 1 ) and centrifugation, six CSF supernatants samples were homogenized and distributed into 11 different tubes (A to K, see Table 1 ) and left at 2-8 • C for 15 min (T1) or for 24 h (T2) before A␤ 42 , hTau, and p-Tau181P were measured using commercially available ELISA tests. For each individual sample, the measured concentrations were converted as a percentage of the mean of the values obtained in the 11 tubes. Results are presented as medians and interquartile ranges. Statistical analysis showed no differences (p-values below 0.05) between T1 and T2 in the 11 tubes. A␤, amyloid-␤ protein; hTau, total Tau protein; p-Tau181P, Tau protein phosphorylated at position 181. of their impact on the three classical AD biomarkers, as well as carrying out a surface polymer composition analysis using differential scanning calorimetry and Fourier Transformed Infrared spectroscopy. This revealed surprising results with only one tube consisting of pure polypropylene, the others being copolymers with at least polyethylene; even-though they were all labeled as polypropylene (Table 1) . Regulations in fact allow companies to label tubes as being purely polypropylene even in the presence of other polymers or surface treatment. Incidentally, the exact polymer composition of the different tubes was not disclosed by most of the commercial providers. Using a series of fresh (unfrozen) CSF samples from 6 patients, we then distributed them between the 11 tubes and waited 15 min (T1) or 24 h (T2) before processing the samples using the same analytical conditions (Table 2 ). This revealed significant differences between tubes (Table 2) with maximum median variations of −48%/+31%, −8%/+8%, and −4%/+6%, for A␤ 42 , hTau, and p-Tau181P, respectively.
When hTau and p-Tau181P were in the range of acceptable and observed analytical variations for these biomarkers, differences in A␤ 42 concentrations clearly exceeded them. The effect was present after 15 min (T1), and an additional 24 h (T2) incubation time at 2-8 • C did not significantly change these values (Fig. 3) .
Adsorption of the biomarkers on the tube surface was the most likely explanation for this "tube effect" [17] . This explanation is consistent with previous unpublished observations suggesting that CSF biomarker levels in samples with high protein content (>1.5 g/L) were not changed by the type of collection tube, especially in comparison with samples with low protein content. To confirm this observation, we confirmed that artificially raising the protein content of CSF samples resulted in a disappearance of the tube effect (Fig. 1B) . This was also coherent with the time course of this effect that was tested in the tube with the apparent higher A␤ values (ST-PP, Fig. 1C ). This experiment revealed a 20% decrease in A␤ peptides concentration as early as 5 min after contact with the tube. This means that when CSF is in contact with a tube, A␤ peptide values drop almost immediately, and this effect is iterative (values drops again when put in a new tube; not shown). Importantly, after these first 5 min, the impact of additional time (24 and 48 h), mimicking a pre-analytical delay, was minimal and not significant up to 48 h (Figs. 1C and 3) . Surprisingly, the pure polypropylene tube (tube K) did not give the best results and differences between tubes suggested that additional surface treatment could also change the adsorption properties of the tubes.
DISCUSSION
The high pre-analytical sensibility of A␤ to different polymer/plastic surfaces is an important observation to take into account. Transfer of CSF in to different tubes during processing or storage can result in a 20% to 60% decrease in measured concentrations. In addition, analytical protocols often contain intermediate steps involving transfer of CSF samples into new tubes or plates, resulting in possible errors. This is true, not only for A␤ 42 , but also for other A␤ peptides (A␤ 40 ,A␤ 38 , not shown), which are of interest for the diagnosis of other neurological diseases [18] . Selection of collection tubes that would preserve the best A␤ peptides content would therefore make sense.
Adsorption of these analytes to the tube walls is the most likely explanation for these phenomena. An interesting trend was observed since some tubes that performed better for p-Tau181P were the worst for A␤ 42 (tubes D and A). This suggests that the hydrophilic/hydrophobic balance of the analytes plays an important role in this phenomenon: the more hydrophobic A␤ 42 peptide is greatly adsorbed by some of the tubes. On the other hand, probably due to its high content in anionic phosphate groups, p-Tau181P which is more hydrophilic, is less adsorbed by the tubes which adsorbed the A␤ 42 protein. Hydrophilicity due to the polymer surface composition is an important point in understanding the adsorption of proteins but other parameters may affect this absorption such as the polymer surface charge in regard with the isoelectric point of the protein, or the surface roughness [16, 19, 20] . It has been shown that changing both the hydrophilicity and the charge of the surface may lead to great improvement in the protein recovery [21] underlying the fact that the tube composition and its possible surface treatment is a key parameter in protein adsorption.
In summary, our data indicated that the preanalytical impact of sampling/processing tubes has to be particularly well optimized and harmonized for multi-site studies and for the definition of relevant and worldwide AD biomarker cut-off values. One way to go is probably to define a consensus protocol that specifically links cut-off values to given sampling tubes and handling/analytical protocols.
